AFG
ITCI

Atomi Financial Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Atomi Financial Group’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,216
Closed -$292K – 1183
2025
Q1 		$292K Buy
+2,216
New +$276K 0.01% 779

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Atomi Financial Group's ITCI Position: Q2 2025 in Review

Atomi Financial Group sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 2,216 shares — an estimated $292K sold.

Atomi Financial Group first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $292K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Atomi Financial Group reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Atomi Financial Group sold 2,216 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $292K.
  • Atomi Financial Group first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
  • Atomi Financial Group's Intra-Cellular Therapies Inc. position peaked at $292K in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Atomi Financial Group's 13F filing for Q2 2025, filed 14 Aug 2025.